Estrella Immunopharma (Estrella Immunopharma) Total Liabilities : $0.14 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Estrella Immunopharma Total Liabilities?

Estrella Immunopharma's Total Liabilities for the quarter that ended in Mar. 2024 was $0.14 Mil.

Estrella Immunopharma's quarterly Total Liabilities declined from Sep. 2023 ($17.28 Mil) to Dec. 2023 ($0.40 Mil) and declined from Dec. 2023 ($0.40 Mil) to Mar. 2024 ($0.14 Mil).

Estrella Immunopharma Total Liabilities Historical Data

The historical data trend for Estrella Immunopharma's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Estrella Immunopharma Total Liabilities Chart

Estrella Immunopharma Annual Data

Trend

Jun21

Total Liabilities

Estrella Immunopharma Quarterly Data
	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial					9.53	-	17.28	0.40	0.14

Estrella Immunopharma Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Estrella Immunopharma's Total Liabilities for the fiscal year that ended in Jun. 2021 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	N/A

Total Liabilities	=	Total Assets (A: Jun. 2021 )	-	Total Equity (A: Jun. 2021 )
	=	N/A	-	N/A
	=	N/A

Estrella Immunopharma's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0.138	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	0.14

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	8.633	-	8.495
	=	0.14

Estrella Immunopharma Total Liabilities Related Terms

Thank you for viewing the detailed overview of Estrella Immunopharma's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Estrella Immunopharma (Estrella Immunopharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Estrella Immunopharma Inc (NAS:ESLAW) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

ESLA:USA

Address

5858 Horton Street, Suite 170, Emeryville, CA, USA, 94608

Website

https://www.estrellabio.com

Estrella Immunopharma Inc is a preclinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer.

Estrella Immunopharma (Estrella Immunopharma) Headlines

No Headlines